Persistent Asset Partners’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Persistent Asset Partners’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$173K	Buy	+126,943	New	+$223K	0.05%	221

Other funds holding NBP

Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return

UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return

Renaissance Technologies New York $73.4B AUM 32.8% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $25.3B AUM 15.9% 1-Year Est. Return

State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.8B AUM 17.58% 1-Year Est. Return

Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Persistent Asset Partners's NBP Position: Q3 2026 in Review

Persistent Asset Partners opened a new position in NovaBridge Biosciences American Depositary Shares (NBP) in Q3 2026: 126,943 shares worth $173K. The stake represents 0.05% of the portfolio and ranks #221 among its holdings.

30 funds tracked by Wall St. Rank hold NBP as of Q3 2026.

Persistent Asset Partners held 126,943 shares of NovaBridge Biosciences American Depositary Shares worth $173K as of Q3 2026.
NovaBridge Biosciences American Depositary Shares was a new Persistent Asset Partners position in Q3 2026.
NovaBridge Biosciences American Depositary Shares made up 0.05% of Persistent Asset Partners's portfolio in Q3 2026, its #221 holding.
30 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.